Bednarz L - Search Results

1

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.

Lin CW, Bianchi BR, Miller TR, Stashko MA, Wang SS, Curzon P, Bednarz L, Asin KE, Britton DR. Lin CW, et al. Among authors: bednarz l. J Pharmacol Exp Ther. 1996 Mar;276(3):1022-9. J Pharmacol Exp Ther. 1996. PMID: 8786531

2

Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.

Asin KE, Bednarz LM. Asin KE, et al. Among authors: bednarz lm. Neurosci Lett. 1990 Jun 8;113(3):286-91. doi: 10.1016/0304-3940(90)90599-5. Neurosci Lett. 1990. PMID: 2143274

3

Differential effects of CCK-JMV-180 on food intake in rats and mice.

Asin KE, Bednarz L. Asin KE, et al. Among authors: bednarz l. Pharmacol Biochem Behav. 1992 Jun;42(2):291-5. doi: 10.1016/0091-3057(92)90529-o. Pharmacol Biochem Behav. 1992. PMID: 1631182

4

A68930: a potent agonist selective for the dopamine D1 receptor.

DeNinno MP, Schoenleber R, MacKenzie R, Britton DR, Asin KE, Briggs C, Trugman JM, Ackerman M, Artman L, Bednarz L, et al. DeNinno MP, et al. Among authors: bednarz l. Eur J Pharmacol. 1991 Jun 25;199(2):209-19. doi: 10.1016/0014-2999(91)90459-4. Eur J Pharmacol. 1991. PMID: 1683288

5

Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.

Asin KE, Bednarz L, Nikkel A, Perner R. Asin KE, et al. Among authors: bednarz l. J Pharmacol Exp Ther. 1995 Jun;273(3):1483-90. J Pharmacol Exp Ther. 1995. PMID: 7791123

6

MK-801 differentially affects dopamine D1 and D2 receptor agonist-induced behavioral tolerance and desensitization.

Asin KE, Bednarz L, Nikkel AL. Asin KE, et al. Among authors: bednarz l. Brain Res. 1996 Jun 24;725(1):67-74. doi: 10.1016/0006-8993(96)00348-4. Brain Res. 1996. PMID: 8828587

7

Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.

Shiosaki K, Asin KE, Britton DR, Giardina WJ, Bednarz L, Mahan L, Mikusa J, Nikkel A, Wismer C. Shiosaki K, et al. Among authors: bednarz l. Eur J Pharmacol. 1996 Dec 19;317(2-3):183-90. doi: 10.1016/s0014-2999(96)00718-2. Eur J Pharmacol. 1996. PMID: 8997599

8

Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior.

Asin KE, Davis JD, Bednarz L. Asin KE, et al. Among authors: bednarz l. Psychopharmacology (Berl). 1992;109(4):415-21. doi: 10.1007/BF02247717. Psychopharmacology (Berl). 1992. PMID: 1365856

9

Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.

Holladay MW, Bennett MJ, Tufano MD, Lin CW, Asin KE, Witte DG, Miller TR, Bianchi BR, Nikkel AL, Bednarz L, et al. Holladay MW, et al. Among authors: bednarz l. J Med Chem. 1992 Aug 7;35(16):2919-28. doi: 10.1021/jm00094a001. J Med Chem. 1992. PMID: 1501220

10

A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey.

Asin KE, Bednarz L, Nikkel AL, Gore PA Jr, Nadzan AM. Asin KE, et al. Among authors: bednarz l. Pharmacol Biochem Behav. 1992 Aug;42(4):699-704. doi: 10.1016/0091-3057(92)90017-a. Pharmacol Biochem Behav. 1992. PMID: 1513850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page